For patients with mild TED, supportive care including ocular surface management offers substantial benefit. Selenium supplementation has also been examined for the treatment of mild, active TED ...

Thyroid eye disease (TED) therapy Tepezza – the top asset in Amgen's $26 billion takeover of Horizon in 2023 – could be facing competition from an easier-to-dose alternative from Sling ...

Modifiable risk factors for thyroid eye disease include smoking habits and patient endocrine status. Avoid treating patients with active TED with radioactive iodine ablation. KOLOA, Hawaii ...

This condition is the most common cause of hypothyroidism in the United States. Hypothyroidism is an underactive thyroid, or when the gland does not make enough hormones. Hashimoto's disease ...

LCA-0321 is a LYTAC degrader designed to specifically bind and rapidly deplete anti-TSHR autoantibodies, the underlying cause of Graves’ disease and its extrathyroidal manifestations, including ...

Eye-disease-focused Acelyrin will be absorbed into immune-mediated disease specialist Alumis as part of an all-stock merger.

KOLOA, Hawaii — Effective management of thyroid eye disease requires a focus on mitigating modifiable risk factors, according to a presenter at Hawaiian Eye 2025. Linsitinib, an oral small ...

Findings showed a statistically significant reduction in proptosis in the linsitinib 150mg twice daily group, with a proptosis responder rate of 52% at week 24. Topline results were announced from ...